Clinical Trials Directory

Trials / Unknown

UnknownNCT05533567

Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Second Affiliated Hospital of Nanchang University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

How anesthetic drugs induce and maintain the behavioral state of general anesthesia is an important question in medicine and neuroscience. Different anesthetic drugs act on different molecular targets and neural circuit mechanisms, exhibiting drug-specific EEG features. As a novel ultra-short-acting benzodiazepines drugs, remimazolam has been accepted for induction and maintenance of clinical anesthesia. Compared to the traditional benzodiazepines drugs, remimazolam combines the safety of midazolam with the effectiveness of propofol, and also has the advantages of acting quickly, short half-life, no injection pain, slight respiratory depression, independent of liver and kidney metabolism, long-term infusion without accumulation, and has a specific antagonist: flumazenil. This study aimed to investigate the differences in the characteristics of EEG oscillations during general anesthesia by comparing propofol and remimazolam.

Conditions

Interventions

TypeNameDescription
DRUGRemimazolamThe experimental group was sedated with remimazolam.
DRUGPropofolThe control group was sedated with propofol.

Timeline

Start date
2022-10-01
Primary completion
2023-01-31
Completion
2023-01-31
First posted
2022-09-09
Last updated
2022-09-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05533567. Inclusion in this directory is not an endorsement.